Eco Animal Health Group PLC Director/PDMR Dealings (8497G)

TIDMEAH

RNS Number : 8497G

Eco Animal Health Group PLC

01 April 2022

ECO Animal Health Group plc

("ECO", the "Company" or the "ECO Group") (AIM: EAH)

Director/PDMR Dealings

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has been notified that on 31 March 2022, Christopher Wilks, Chief Financial Officer, purchased 16,000 Ordinary Shares of 5 pence each ("Ordinary Shares") at a price of 163 pence per share.

Following this transaction, Christopher Wilks' total interest in the Company is 150,095 Ordinary Shares, representing approximately 0.22 per cent. of the Company's issued share capital.

Details of the transactions can be found in the Notification of Dealing Form below.

For further information please contact:

 
 
   ECO Animal Health Group plc 
   Marc Loomes (CEO) 
   Christopher Wilks (CFO)                     020 8447 8899 
 IFC Advisory 
  Graham Herring 
  Zach Cohen                                  020 3934 6630 
 Singer Capital Markets (Nominated Adviser 
  & Joint Broker) 
  Mark Taylor 
  George Tzimas                               020 7496 3000 
 Investec (Joint Broker) 
  Gary Clarence 
  Alex Penney                                 020 7597 5970 
  Carlo Spingardi 
 
  Peel Hunt LLP (Joint Broker) 
  Dr Christopher Golden 
  James Steel                                  020 7418 8900 
 
 
 Equity Developments 
  Hannah Crowe 
  Matt Evans            020 7065 2692 
 

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                                    Christopher Wilks 
      --------------------------------------  -------------------------------------- 
 2     Reason for the notification 
      ------------------------------------------------------------------------------ 
 a)    Position/status                         Chief Financial Officer 
      --------------------------------------  -------------------------------------- 
 b)    Initial notification                    Initial notification 
        /Amendment 
      --------------------------------------  -------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ------------------------------------------------------------------------------ 
 a)    Name                                    ECO Animal Health Group plc 
      --------------------------------------  -------------------------------------- 
 b)    LEI                                     2138009XN9DJ3YP70B55 
      --------------------------------------  -------------------------------------- 
 4     Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ------------------------------------------------------------------------------ 
 a)    Description of the                      Ordinary shares of 5 pence each 
        financial instrument, 
        type of instrument 
 
       Identification code                     GB0032036807 
 
 b)    Nature of the transaction               Purchase of Ordinary Shares 
      --------------------------------------  -------------------------------------- 
 c)    Price(s) and volume(s) 
                                               -----------------  ---------------- 
                                                Price(s)           Volume(s) 
                                               -----------------  ---------------- 
    163 pence                                                      16,000 
   -------------------------------------------------------------  ---------------- 
 
 d)    Aggregated information                  N/A - Single transaction 
 
  - Aggregated volume 
 
  - Price 
 
 e)    Date of the transaction                 31 March 2022 
      --------------------------------------  -------------------------------------- 
 f)    Place of the transaction                London Stock Exchange, AIM 
      --------------------------------------  -------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBKDBQABKDANN

(END) Dow Jones Newswires

April 01, 2022 02:01 ET (06:01 GMT)